| Althea Group Holdings Limited (AGH) ORDINARY FULLY PAID |
Health Care |
$21 |
AGH FY24 Annual Report Commentary
|
30 Aug 2024 10:08AM |
$0.020 |
$0.026 |
risen by
30%
|
|
AGH - Price-sensitive ASX Announcement
Full Release
Key Points
- AGH reported a 21% revenue increase, reaching $30.36 million in FY24.
- Strategic cost-saving measures are projected to save $2.5 million annually from May 2024.
- Althea saw a 46% revenue increase in the UK.
- Peak Processing Solutions in Canada is expected to have substantial growth in FY25.
- AGH plans to enter the US market via Peak USA Inc. in September 2024.
- A non-cash impairment of $17.74 million was recorded for Peak Canada.
- Management identified an additional $1.5 million in annual cost savings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$361 |
Appendix 4E
|
30 Aug 2024 10:08AM |
$0.178 |
$0.273 |
risen by
53.52%
|
|
TTT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues from ordinary activities increased by 71.5% to $7,697,370
- Loss from ordinary activities after tax decreased by 24.3% to $11,892,164
- Total comprehensive loss attributable to owners decreased by 23.4% to $11,994,468
- No dividends were paid, recommended, or declared during the current financial period
- Net tangible assets per ordinary security improved from -0.0030 cents to 0.0010 cents
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Serko Limited (SKO) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$344 |
Application for quotation of securities - SKO
|
30 Aug 2024 10:07AM |
$2.900 |
$2.760 |
fallen by
4.83%
|
|
| Althea Group Holdings Limited (AGH) ORDINARY FULLY PAID |
Health Care |
$21 |
Annual Report to shareholders
|
30 Aug 2024 10:07AM |
$0.020 |
$0.026 |
risen by
30%
|
|
AGH - Price-sensitive ASX Announcement
Full Release
Key Points
- Althea Group Holdings Limited (AGH) operates two distinct business units: Althea (pharmaceutical) and Peak Processing Solutions (recreational cannabis).
- AGH reported a revenue of $30.36 million for the fiscal year ended June 30, 2024, an increase of 21% from the previous year.
- The company's global sales revenue for pharmaceutical cannabis reached $17.72 million, achieving an EBITDA positive result.
- In Australia, Althea achieved a revenue of $7.39 million in the first half of FY24.
- Peak Processing Solutions achieved a sales revenue of $11.68 million in FY24, a 19% increase from the previous year.
- Peak Processing Solutions faced a $17.74 million impairment, which is a non-cash accounting adjustment.
- AGH's organizational review is projected to deliver $2.5 million in annualized cost savings.
- AGH launched new products in February 2024, including Althea CBD3:THC2 and Althea THC10 soft gel capsules.
- Althea launched its dried flower range, Atmos by Althea™, in collaboration with Rocket Factory.
- AGH plans to introduce additional Atmos by Althea™ products in the coming months.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Advance Metals Limited (AVM) ORDINARY FULLY PAID |
Materials |
$12 |
Reinstatement to Quotation
|
30 Aug 2024 10:06AM |
$0.025 |
$0.047 |
risen by
88%
|
|
AVM - Price-sensitive ASX Announcement
Full Release
Key Points
- Reinstatement to quotation announced by ASX Limited.
- Suspension of trading in Advance Metals Limited securities to be lifted.
- Reinstatement follows the release of exploration results for the Augustus project in Arizona.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Advance Metals Limited (AVM) ORDINARY FULLY PAID |
Materials |
$12 |
High Grade Copper Assays - Augustus 2024
|
30 Aug 2024 10:06AM |
$0.025 |
$0.047 |
risen by
88%
|
|
AVM - Price-sensitive ASX Announcement
Full Release
Key Points
- Initial assay results confirm high grade mineralization at Augustus.
- 32 out of 34 samples returned grades over 1.0% Cu.
- Significant thick veins ranging from 1m-3m have been mapped.
- Mineralization identified in bedrock below alluvium and in creek beds.
- Assay results from sampling program ranged from 0.1% to 20.8% Copper.
- Sampling program targeted known adits, mine portals, shafts, and veins across the project area.
- New areas of mineralization seen in creek beds and below alluvial cover.
- Further analysis on gold and other element assay results to be reported.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$8 |
Appendix 4E and Preliminary Final Report
|
30 Aug 2024 10:04AM |
$0.019 |
$0.004 |
fallen by
78.95%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for ordinary activities remained at zero.
- The company reported a net loss of $12,529,849, down by 51.7% from the previous year.
- No dividends were paid or declared for the current or previous financial year.
- Net assets for the group were $2,470,068 as at 30 June 2024.
- Cash reserves stood at $3,053,001 as at 30 June 2024.
- The company engaged in significant intellectual property acquisitions, including Chlorotoxin CAR-T, CDH-17, and CORE-NK technologies.
- Various milestones and contingent considerations related to intellectual property licenses are detailed.
- The financial statements include a consolidated statement of profit or loss and other comprehensive income, consolidated statement of financial position, and consolidated statement of cash flows.
- The financial report highlights a scale-down of headcount and a reduction in general and administration expenses.
- The financial statements are currently in the process of being audited, with final audited statements expected by 30 September 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Danakali Limited (DNK) ORDINARY FULLY PAID |
Materials |
$151 |
Unclaimed Shareholder Distributions
|
30 Aug 2024 10:03AM |
$0.410 |
$0.410 |
fallen by
0%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,840 |
Appendix 3C
|
30 Aug 2024 10:01AM |
$42.705 |
$51.765 |
risen by
21.22%
|
|
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$19 |
Cummins Range Development Update
|
30 Aug 2024 10:01AM |
$0.013 |
$0.021 |
risen by
61.54%
|
|
REE - Price-sensitive ASX Announcement
Full Release
Key Points
- Cummins Range is Australia's largest undeveloped rare earth and significant phosphate project
- Rare earths metallurgy and engineering placed on hold until metal prices recover
- Early phosphate product generation being investigated as a standalone stage
- Phosphate metallurgical program has produced samples for testing with offtake market
- Alternative phosphate technology in testing for potential reduction in start-up costs
- Ordco under MoU for Offtake and product R&D which may be supplied with Stage-1 product from alternative technology
- Supply chain to Wyndham Port de-risked with infrastructure sharing agreement
- Native Title heritage agreement discussions ongoing with new representatives
- Development includes leveraging phosphate content as a low capital entrance into operations before expanding into rare earths
- Environmental baseline monitoring completed for pre-engagement with regulators
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pan Asia Metals Limited (PAM) ORDINARY FULLY PAID |
Materials |
$10 |
RK Lithium Project - KT East Geometry Ticks the Boxes
|
30 Aug 2024 10:00AM |
$0.071 |
$0.049 |
fallen by
30.99%
|
|
PAM - Price-sensitive ASX Announcement
Full Release
Key Points
- Soil sampling increases the anomalous lithium zone at KT East.
- The pegmatite field at KT East covers a strike length of 2.1km and width of up to 1.5km.
- The geometry of the pegmatite field is amenable to open pit mining.
- KT East's footprint is larger than both the RK and BT Lithium Prospects combined.
- Further sampling, mapping, and potential trenching are being planned at KT East.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,840 |
Appendix 3C
|
30 Aug 2024 10:00AM |
$42.705 |
$51.765 |
risen by
21.22%
|
|
| Healius Limited (HLS) ORDINARY FULLY PAID |
Health Care |
$559 |
Change of Director's Interest Notice
|
30 Aug 2024 9:59AM |
$1.650 |
$0.770 |
fallen by
53.33%
|
|
| Halo Technologies Holdings Ltd (HAL) ORDINARY FULLY PAID |
Financials |
$3 |
HALO Invest Business Update
|
30 Aug 2024 9:59AM |
$0.061 |
$0.021 |
fallen by
65.57%
|
|
HAL - Price-sensitive ASX Announcement
Full Release
Key Points
- HALO Invest is establishing a new operations and development center in Glasgow.
- The project is supported by an £800,000 grant from Scottish Enterprise.
- More than 60 jobs are expected to be created over the next two years.
- Douglas Boyce has been appointed Chief Executive Officer of HALO Invest.
- The project is expected to cost around £8 million.
- The launch of HALO Invest in the UK is a key strategic milestone for HALO Technologies Holdings Ltd.
- HALO Invest executed its first trades in the UK, meeting regulatory and infrastructure requirements ahead of schedule.
- HALO is developing services tailored for UK Financial Advisors, including General Investment Accounts, ISAs, and SIPPs.
- HALO Technologies Holdings Ltd is listed on the Australian Securities Exchange and was founded in 2017.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infinity Mining Limited (IMI) ORDINARY FULLY PAID |
Materials |
$3 |
Chairman's Address for Annual General Meeting
|
30 Aug 2024 9:59AM |
$0.019 |
$0.008 |
fallen by
57.89%
|
|
IMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Infinity Mining Limited is holding its Annual General Meeting with Joe Phillips as the Executive Chairman.
- The company has 100% interest in tenements located in East Pilbara and Central Goldfields regions of Western Australia.
- Focus on lithium exploration in Pilbara tenements.
- Positive exploration results in Pilbara and Central Goldfields for lithium, copper, nickel, and gold.
- In 2023, a successful drilling program yielded an aggregate inferred 60,300 ounces of gold resource.
- New acquisitions in New South Wales, Victoria, and Tasmania for gold, copper, and other base metals.
- Several gold projects in historically productive regions with promising geological settings.
- Projects with diverse mineralisation including copper, tungsten, molybdenum, tin, and other base metals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Canyon Resources Ltd (CAY) ORDINARY FULLY PAID |
Materials |
$372 |
30 June Quarterly Activities Report Additional Information
|
30 Aug 2024 9:59AM |
$0.078 |
$0.243 |
risen by
210.90%
|
|
| Healius Limited (HLS) ORDINARY FULLY PAID |
Health Care |
$559 |
Change of Director's Interest Notice
|
30 Aug 2024 9:59AM |
$1.650 |
$0.770 |
fallen by
53.33%
|
|
| Shekel Brainweigh Ltd (SBW) ORDINARY FULLY PAID |
Information Technology |
- |
Investor Presentation Webinar
|
30 Aug 2024 9:57AM |
$0.050 |
$0.021 |
fallen by
58%
|
|
| Solis Minerals Ltd (SLM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$12 |
Audited Financial Statements and MD&A for FYE 31 May 2024
|
30 Aug 2024 9:57AM |
$0.090 |
$0.085 |
fallen by
5.56%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$15 |
Appendix 4E and Preliminary Final Report
|
30 Aug 2024 9:56AM |
$0.095 |
$0.062 |
fallen by
34.74%
|
|
IMC - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported financial loss of A$6.93 million for the year ended 30 June 2024.
- Net assets decreased to A$12.71 million, with cash reserves at A$11.66 million.
- Revenue from ordinary activities increased by 171.7% to A$4.90 million.
- Sales of Travelan® significantly increased in Australia and the USA.
- Completion of Phase 2 clinical trial for IMM-124E.
- Completion of inpatient phase of CampETEC Phase 2 clinical trial.
- Submission of pre-IND application for IMM-529 to the FDA.
- Travelan® clinical field trial reached 77% recruitment.
- U.S. Department of Defense funded research on enhanced formulations of Travelan®.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mosaic Brands Limited (MOZ) ORDINARY FULLY PAID |
Consumer Discretionary |
$6 |
Timing of preliminary financial report
|
30 Aug 2024 9:56AM |
$0.030 |
$0.036 |
risen by
20%
|
|
| Maggie Beer Holdings Ltd (MBH) ORDINARY FULLY PAID |
Consumer Staple |
$24 |
FY24 Preliminary Final Report
|
30 Aug 2024 9:56AM |
$0.067 |
$0.068 |
risen by
1.49%
|
|
MBH - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues from ordinary activities increased by 0.8% to $89.4 million.
- The consolidated entity reported a net loss of $28.2 million for the year.
- Significant impairment expenses totaling $18.3 million were recognized.
- Maggie Beer Products saw a 6.3% increase in net sales.
- Hampers & Gifts Australia recorded a 0.7% increase in net sales.
- Paris Creek Farms experienced a 9.5% decline in net sales due to lower milk supply.
- Gross margin decreased by 1.1 percentage points to 49.2%.
- Trading EBITDA was $0.3 million, down from $3.2 million in the previous year.
- The company has no debt and had a net cash position of $4.7 million as of 30 June 2024.
- The company's net assets decreased from $85.7 million to $57.8 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Excelsior Capital Ltd (ECL) ORDINARY FULLY PAID |
Industrials |
$92 |
Earn-out Update
|
30 Aug 2024 9:55AM |
$3.240 |
$3.190 |
fallen by
1.54%
|
|
ECL - Price-sensitive ASX Announcement
Full Release
Key Points
- Excelsior Capital Limited (ECL) provides an update on the earn-out payment related to the sale of CMI Operations Pty Ltd.
- No earn-out payment will be payable to ECL based on IPD Group Limited's full-year reporting.
- ECL has not accrued any earn-out amount in its full-year financial reports.
- ECL has the right to review the income statement and FY24 EBIT calculations of CMI Electrical prepared by IPD.
- ECL is currently reviewing the information provided by IPD.
- Updates will be provided if any changes in relation to the earn-out payment are determined.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Immutep Limited (IMM) ORDINARY FULLY PAID |
Health Care |
$329 |
Appendix 4E & 2024 Full Year Statutory Accounts
|
30 Aug 2024 9:55AM |
$0.388 |
$0.225 |
fallen by
41.94%
|
|
IMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported a loss after tax of $42,716,625 for FY2024.
- Raised approximately A$100 million through equity issuance.
- Advanced lead product eftilagimod alpha (efti) in various clinical trials.
- Secured positive regulatory feedback for Phase III TACTI-004 trial in 1L NSCLC.
- Developing LAG-3 agonist IMP761 for autoimmune diseases.
- Entered research collaborations with Monash University and Cardiff University.
- Received grants and increased interest income, contributing to financial position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metrics Income Opportunities Trust (MOT) ORDINARY UNITS FULLY PAID |
Financials |
$664 |
Appendix 4G Key to Corporate Governance Disclosure FY 24
|
30 Aug 2024 9:55AM |
$2.190 |
$1.995 |
fallen by
8.90%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
